Navigation Links
2012 US Coagulation Market Outlook: Growth Opportunities and Strategies
Date:7/9/2012

NEW YORK, July 9, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

2012 US Coagulation Market Outlook: Growth Opportunities and Strategies

http://www.reportlinker.com/p0845324/2012-US-Coagulation-Market-Outlook-Growth-Opportunities-and-Strategies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

This report presents a comprehensive analysis of the US coagulation market, including:

·         Major issues pertaining to the US coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.

·         Ten-year volume and sales forecasts for 40 coagulation procedures performed in US hospitals, commercial laboratories, and physician offices, including typical coagulation daily work loads.

·         Placement estimates for major automated and semiautomated systems.

·         Review of current instrumentation technologies, and a feature comparison of nearly 50 leading analyzers.

·         Ten-year reagent and instrument sales forecasts.

·         Sales and market shares of leading reagent and instrument suppliers.

·         Review of coagulation technologies and their potential market applications.

·         Major opportunities for coagulation instruments and consumables.

·         Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

·         Business opportunities and strategic recommendations for instrument and reagent suppliers.

Contains 424 pages and 18 tables

Table of Contents

Worldwide Market and Technology Overview

A. Major Routine and Special Coagulation Tests

1. Introduction

2. Activated Partial Thromboplastin Time (APTT)

3. Alpha-2 Antiplasmin

4. Antithrombin III

5. Bleeding Time

6. D-Dimer

7. Ethanol Flocculation Test

8. Euglobulin Lysis

9. Factor Assays

a. Introduction

b. Factor II

c. Factor V/Factor V Leiden

d. Factor VII

e. Factor VIII

f. Factor IX

g. Factor IXa

h. Factor X (Stuart Factor)

i. Factor Xa

j. Factor XI

k. Factor XII

l. Factor XIII

10. Fibrin Degradation Products

11. Fibrinogen

12. Heparin

13. Hirudin

14. Hypercoagulability and Thrombosis

15. Lipoprotein a

16. Plasmin

17. Plasminogen

18. Plasminogen Activator Inhibitor (PAI)

19. Platelet Function Tests

20. Platelet Aggregation

21. Proteins C and S

22. Prothrombin Fragment 1.2

23. Prothrombin Time (PT)

24. Reptilase Time

25. Thrombin Time

26. Tissue-Type Plasminogen Activator (t-PA)

27. Von Willebrand's Factor

B. Instrumentation Review

- Introduction

- Benk Hemolab

- Benk TRT Thrombotimer

- Bio/Data MCA 310

- Bio/Data MCA 210

- Bio/Data PAP-4C D/4D/4C

- Cardiovascular Diagnostics COAG

- Diagnostica Stago STA Compact

- Diagnostica Stago STA-R

- Diagnostica Stago Star 4/8

- Helena Laboratories Cascade 480

- Helena Laboratories Cascade M

- Helena Laboratories PACKS-4

- Helena THOR

- Instrumentation Laboratory ACL 100 and 1000 series

- Instrumentation Laboratory ACL6000

- Instrumentation Laboratory ACL7000

- Instrumentation Laboratory ACL9000

- Instrumentation Laboratory Electra 1000C

- Instrumentation Laboratory Electra 1400C

- Instrumentation Laboratory Electra 1600/C

- Instrumentation Laboratory Electra 1800C

- Instrumentation Laboratory Futura

- ITC Hemochron 8000

- Roche Diagnostics CoaguChek

- Siemens BCS

- Siemens BCT

- Siemens BF II/Fibrintimer Series

- Sysmex CA-50

- Sysmex CA-500

- Sysmex CA-1500

- Sysmex CA-5000/CA-1000

- Sysmex CA-6000

- Sysmex CA-7000

- Teco Coatron II/Jr./AccuStasis 5000

- Trinity Biotech Amax CS190

- Trinity Biotech Amax CS400

- Trinity Biotech Coag-A-Mate Max

- Trinity Biotech KC 40, 4A, 1A Series

- Trinity Biotech MDA 180

- Trinity Biotech Coag-A-Mate MTX

- Trinity Biotech Coag-A-Mate RA4

- Trinity Biotech Coag-A-Mate XC/Plus

- Trinity Biotech Coag-A-Mate XM

C. Major in Vitro Diagnostic Technologies and Their

Potential Applications

1. Chromogenic Substrates

2. Monoclonal and Polyclonal Antibodies

3. Immunoassays

a. Applications

b. Technological Principle

c. Enzyme Immunoassays (EIA)

- Overview

- ELISA

- EMIT

- Dot Immunobinding Assays

- Capillary Immunoassays

- Enzyme Amplification

- Electrochemical Immunoassay

d. Fluorescent Immunoassays

- Fluorescence Polarization

- Time-Resolved Pulse Fluorescence

- Fluorescence Lifetime

e. Latex Agglutination

f. Immunoprecipitation

4. Microcomputers

5. Automation

6. Robotics

7. DNA Probes

a. Overview

b. Amplification Methods

- PCR

- Ligase Chain Reaction

- Branched DNA

- Q-Beta Replicase

- NASBA

- SDA

- 3 SR

- HPA

- Two-Tiered System

- LAT

8. Artificial Intelligence

9. Dry Chemistry

10. Biosensors

D. Worldwide Market Overview

1. Business Environment

2. Market Structure

3. Market Size and Growth

4. POC Testing Market

USA

A. Executive Summary

B. Business Environment

1. Health Care Expenditures

2. Cost Consciousness

3. Industry Consolidation

4. Managed Care

5. Hospitals

6. Admissions

7. Length of Stay

8. Industry Diversification

9. Physician Demographics

10. Population Aging

a. Chronic Illnesses

b. Disease Incidence

c. Susceptibility to Iatrogenesis

d. Multiple Illness Cases

11. Laboratory Regulations

C. Market Structure

1. Centralized Testing

a. Hospitals

b. Commercial laboratories

2. Decentralized Testing

a. Physician Offices/Group Practices

b. Point-of-Care Testing

c. Home/Self Testing

d. Other Decentralized Testing Locations

D. Market Size, Growth And Major Suppliers

Major Product Development Opportunities

Design Criteria For Decentralized Testing Products

Alternative Market Penetration Strategies

A. Internal Development

B. Collaborative Arrangements

C. University Contracts

D. Distribution Strategies for Decentralized Testing Markets

1. Marketing Approaches

2. Product Complexity

3. Customer Preference

4. Established Suppliers

5. Emerging Suppliers

6. Major Types Of Distributors

7. Market Segmentation

Potential Market Entry Barriers And Risks

A. Market Maturity

B. Cost Containment

C. Competition

D. Technological Edge And Limitations

E. Patent Protection

F. Regulatory Constraints

G. Decentralized Testing Market Challenges

Competitive Assessments

- Abbott

- American Diagnostica

- Avocet Medical

- Axis-Shield

- Beckman Coulter

- Becton Dickinson

- Bio/Data Corporation

- Biosite

- Chrono-Log

- Corgenix Medical

- Diagnostica Stago

- Helena Laboratories

- HYPEN BioMed

- Instrumentation Laboratory

- ITC

- Nanogen

- Roche

- Siemens

- Sienco

- Sysmex

- Thermo Fischer

- Trinity Biotech

- ZyCare

 

List of Tables

Major Companies Developing or Marketing Activated Clotting Time Tests

Major Companies Developing or Marketing APTT Tests

Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests

Major Companies Developing or Marketing Antithrombin III Tests

Major Companies Developing or Marketing Bleeding Time Tests

Major Companies Developing or Marketing D-dimer Tests

Major Companies Developing or Marketing Factor Assays

Major Companies Developing or Marketing Fibrin Degradation Product Tests

Major Companies Developing or Marketing Fibrinogen Tests

Major Companies Developing or Marketing Heparin Tests

Major Companies Developing or Marketing Plasmin Tests

Major Companies Developing or Marketing Plasminogen Tests

Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests

Major Companies Developing or Marketing Platelet Aggregation Tests

Major Companies Developing or Marketing Protein C Tests

Major Companies Developing or Marketing Protein S Tests

Major Companies Developing or Marketing PT Tests

Major Companies Developing or Marketing Thrombin Time Tests

Major Companies Developing or Marketing TPA Tests

Major Companies Developing or Marketing Von Willebrand's Factor Tests

Worldwide, All Market Segments, Laboratories Performing Coagulation Tests By Country, 2010

Worldwide, All Market Segments, Total Coagulation Test Volume By Country, 2010-2020

Worldwide, All Market Segments, Total Coagulation Reagent Market By Country, 2010-2020

Worldwide, All Market Segments, Total Coagulation Instrument Market By Country, 2010-2020

Worldwide, All Market Segments, Total Coagulation Diagnostics Market By Country, 2010-2020

Executive Summary Table: U.S.A., Total Coagulation Diagnostics Market By Market Segment and Product Category, 2010-2020

U.S.A., Laboratories Performing Coagulation Tests By Market Segment, 2010

U.S.A., Hospital Laboratories Performing Coagulation Tests By Bed Size, 2010

U.S.A., Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume, 2010

U.S.A., Physician Offices/Group Practices Performing Coagulation Tests By Practice Size, 2010

U.S.A., Hospital Laboratories Average Daily Test Volume, 2010

U.S.A., Commercial/Private Laboratories Average Daily Test Volume, 2010

U.S.A., Physician Offices/Group Practices Average Daily Test Volume

U.S.A., Total Coagulation Test Volume By Market Segment, 2010-2020

U.S.A., All Market Segments Coagulation Test Volume, 2010-2020

U.S.A., Hospital Laboratories Coagulation Test Volume, 2010-2020

U.S.A., Physician Offices/Group Practices Coagulation Test Volume, 2010-2020

U.S.A., Commercial/Private Laboratories Coagulation Test Volume, 2010-2020

U.S.A., Coagulation Reagent Market By Market Segment, 2010-2020

U.S.A., Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares, 2010

U.S.A., Coagulation Instrument Market By Market Segment, 2010-2020

U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Total Instrument Placements and Market Shares, 2010

U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010

U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares, 2010

U.S.A., Total Coagulation Diagnostics Market By Product Category, 2010-2020

U.S.A., Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares, 2010

To order this report:

In Vitro Diagnostic Industry: 2012 US Coagulation Market Outlook: Growth Opportunities and Strategies

More Market Research Report

Check our Industry Analysis and Insights

Contact Nicolas Bombourg: Reportlinker Email: nicolasbombourg@reportlinker.com US: (805)652-2626 Intl: +1 805-652-2626

 


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. 2012 Global Factor Assays Market Outlook: Test Volume Forecasts by Country and Market Segment
2. Healthcare Cloud Computing (Clinical, EMR, SaaS, Private, Public, Hybrid) Market - Global Trends, Challenges, Opportunities & Forecasts (2012 - 2017)
3. Pressure BioSciences, Inc. Reaches Agreement with Investors on Initial $600,000 Tranche of $1.2 Million Above-Market Private Placement; Proceeds to Support Continued Commercialization of PCT Product Platform
4. Global Neuroendocrine Carcinoma Therapeutics Market To Reach $475m By 2019 - Report
5. Aesthetics Pharmaceutical Company Selects 360 Vantage Closed Loop Marketing Solution for Apple iPad
6. Biosimilars: Global Markets
7. "Biological Control Industry Overview: Companies & Products" Edition 2 is Here. Critical information for Understanding the Global Biopesticide/Biocontrol Market
8. World Biotech API Market Potential Examined in New Topical Study Now Available at MarketPublishers.com
9. Laboratory Equipment Marketplace LabX.com Receives Fresh Look and Updated Features
10. MarketsandMarkets: Global Next Generation Biometric Technologies Market worth $13.89 Billion by 2017
11. Economic Alliance of Greater Baltimore Inks Business Partnership with BioHealth Innovation to Bring Health and Life Sciences Research to Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... STACS DNA Inc., ... Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field ... DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...
Breaking Biology News(10 mins):